NatamycinPseudomonas infection: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1699卷 / 1期

关键词：

D O I：

10.1007/s40278-018-45493-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：225 / 225

相关论文

共 50 条

[1] ImmunosuppressantsBK polyomavirus infection: 5 case reports
Reactions Weekly, 2021, 1838 (1) : 276 - 276
[2] RituximabReactivation of cytomegalovirus infection: 5 case reports
Reactions Weekly, 2020, 1809 (1) : 215 - 215
[3] DecitabineNeutropenia, thrombocytopenia and infection: 5 case reports
Reactions Weekly, 2021, 1884 (1) : 165 - 165
[4] Multiple drugsBacterial infection: 5 case reports
Reactions Weekly, 2017, 1665 (1) : 194 - 194
[5] AntineoplasticsNeuroinvasive Bacillus cereus Infection: 5 case reports
Reactions Weekly, 2025, 2043 (1) : 41 - 41
[6] ImmunosuppressantsKlebsiella pneumoniae and Aspergillus infection: 5 case reports
Reactions Weekly, 2019, 1770 (1) : 210 - 210
[7] AntineoplasticsUnspecified infection and lack of efficacy: 5 case reports
Reactions Weekly, 2022, 1932 (1) : 90 - 90
[8] Multiple drugsClostridioides difficile infection: 5 case reports
Reactions Weekly, 2025, 2043 (1) : 233 - 233
[9] ImmunosuppressantsCOVID-19 infection and cytomegalovirus infection: 5 case reports
Reactions Weekly, 2021, 1861 (1) : 163 - 163
[10] CiclosporinLiver injury, infection and kidney injury: 5 case reports
Reactions Weekly, 2020, 1816 (1) : 102 - 102

← 1 2 3 4 5 →